Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 766 (1) , 99-105
- https://doi.org/10.1016/s0378-4347(01)00432-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Gender-dependent pharmacokinetics of topotecan in adult patientsAnti-Cancer Drugs, 2000
- Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical TrialsJournal of Clinical Oncology, 2000
- Phase I Pharmacologic Study of Oral Topotecan and Intravenous Cisplatin: Sequence-Dependent Hematologic Side EffectsJournal of Clinical Oncology, 2000
- Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humansAnti-Cancer Drugs, 1999
- Femtomole Quantitation of 7-Ethyl-10-hydroxycamptothecine (SN-38) in Plasma Samples by Reversed-Phase High-Performance Liquid ChromatographyAnalytical Biochemistry, 1999
- Role of red blood cells in pharmacokinetics of chemotherapeutic agentsAnti-Cancer Drugs, 1999
- Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Partitioning of Ifosfamide and Its Metabolites between Red Blood Cells and PlasmaJournal of Pharmaceutical Sciences, 1996
- Erythrocytes and the Transport of Drugs and Endogenous CompoundsPharmaceutical Research, 1996
- Description of an instrument for separation of red cells from plasma and measurement of red cell volumeClinical Biochemistry, 1994